the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma
NCT03777475
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
350
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE:
transarterial infusion
Sponsor
Sun Yat-sen University